Holtz, D. O., Krafty, R. T., Mohamed-Hadley, A., Zhang, L., Alagkiozidis, I., Leiby, B., . . . Coukos, G. (2008). Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer. BioMed Central.

Holtz, David O., Robert T. Krafty, Alisha Mohamed-Hadley, Lin Zhang, Ioannis Alagkiozidis, Benjamin Leiby, Wensheng Guo, Phyllis A. Gimotty, and George Coukos. Should Tumor VEGF Expression Influence Decisions On Combining Low-dose Chemotherapy With Antiangiogenic Therapy? Preclinical Modeling in Ovarian Cancer. BioMed Central, 2008.

Holtz, David O., et al. Should Tumor VEGF Expression Influence Decisions On Combining Low-dose Chemotherapy With Antiangiogenic Therapy? Preclinical Modeling in Ovarian Cancer. BioMed Central, 2008.